MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.

in Journal of Clinical Investigation (2013), 123(5), 2143-54

Peripartum cardiomyopathy (PPCM) is a life-threatening pregnancy-associated cardiomyopathy in previously healthy women. Although PPCM is driven in part by the 16-kDa N-terminal prolactin fragment (16K PRL ... [more ▼]

Peripartum cardiomyopathy (PPCM) is a life-threatening pregnancy-associated cardiomyopathy in previously healthy women. Although PPCM is driven in part by the 16-kDa N-terminal prolactin fragment (16K PRL), the underlying molecular mechanisms are poorly understood. We found that 16K PRL induced microRNA-146a (miR-146a) expression in ECs, which attenuated angiogenesis through downregulation of NRAS. 16K PRL stimulated the release of miR-146a-loaded exosomes from ECs. The exosomes were absorbed by cardiomyocytes, increasing miR-146a levels, which resulted in a subsequent decrease in metabolic activity and decreased expression of Erbb4, Notch1, and Irak1. Mice with cardiomyocyte-restricted Stat3 knockout (CKO mice) exhibited a PPCM-like phenotype and displayed increased cardiac miR-146a expression with coincident downregulation of Erbb4, Nras, Notch1, and Irak1. Blocking miR-146a with locked nucleic acids or antago-miRs attenuated PPCM in CKO mice without interrupting full-length prolactin signaling, as indicated by normal nursing activities. Finally, miR-146a was elevated in the plasma and hearts of PPCM patients, but not in patients with dilated cardiomyopathy. These results demonstrate that miR-146a is a downstream-mediator of 16K PRL that could potentially serve as a biomarker and therapeutic target for PPCM. [less ▲]

MicroRNA-146a is a causative factor and a specific biomarker for peripartum cardiomyopathy

Poster (2012, April)

MicroRNA-146a, a downstream effector of 16kDa prolactin, impairs the endothelium-cardiomyocyte cross-talk in peripartum cardiomyopathy

in FASEB meeting:the Growth Hormone/Prolactin Family in Biology and Disease. (2012)

MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy

Poster (2011, March)

MiR-146a: an angiostatic miRNA with tumor-suppressive properties

Poster (2011, February)

MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy

Poster (2011, January)

miR-146a: an anti-angiogenic miRNA regulated by NF-kB

Poster (2010, May 21)

Study of the role of miR-21 in the regulation of angiogenesis

Poster (2010, May)

Study of the role of miR-21 in the regulation of angiogenesis

Poster (2010, March)

Study of the potential regulation of Sprouty1, an angiogenesis inhibitor, by miR-21

Poster (2009, May 29)